34 results
Page 2 of 2
6-K
EX-99.2
ccjexg99
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.3
bvv7x1j tg
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
0wyxa l6f
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
424B4
x70mo kcmrtst3mcdl
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
1ldd mxvpr1qfsvfflay
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
u5onwyn
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-99.1
ljhs1vtael9
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
CORRESP
geaqpsmlnqtw1fwuwyd
8 Mar 21
Correspondence with SEC
12:00am
F-1
hbvl8q8h8spk9e
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.10
1giuhp4 pg3hp32
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.15
irld2n
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
xtapx77fczx6p uvhi
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
ualqru 6nme
17 Dec 20
Draft registration statement
12:00am
DRS
EX-10.7
jl6430snnos9qghdcjw
17 Dec 20
Draft registration statement
12:00am